| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Johnson & Johnson | Paliperidone | Schizophrenia | sNDA Filing | Oral Injectable | Psychiatric | |
| Johnson & Johnson | Ad26.RSV.preF - (CYPRESS) | Respiratory Syncytial Virus (RSV) | NDA Filing | Intramuscular | Respiratory | |
| Johnson & Johnson | SIMPONI (golimumab) | Pediatric Ulcerative Colitis Crohn's Disease (GALAXI) | NDA Filing | Ongoing | Subcutaneous | Gastroenterology |
| Johnson & Johnson | OPSUMIT (macitentan) | Pediatric Pulmonary Arterial Hypertension | NDA Filing | Ongoing | Oral | Cardiology |
| Johnson & Johnson | Icotrokinra (JNJ-2113) - (ICONIC-TOTAL) | Moderate-to-severe psoriasis | NDA Filing | Data Released | Oral | Immunology: Anti-TNF |
| Johnson & Johnson | Macitentan with Tadalafil FDC - (A DUE) | Pulmonary arterial hypertension (PAH) | NDA Filing | Data Released | Oral | Cardiology |
| Johnson & Johnson | Aprocitentan | Difficult to treat hypertension | NDA Filing | Oral | Cardiology | |
| Johnson & Johnson | JNJ-0953 (CD388) - (ANCHOR) | Seasonal Influenza | Phase 3 | Ongoing | Intramuscular | Respiratory |